Apellis Pharmaceuticals, Inc. (APLS) NASDAQ

29.76

+0.98(+3.41%)

Updated at February 05 12:06PM

Currency In USD

Valuation

Market Cap7.1B
Enterprise Value6.86B
P/E Ratio-14.73
PEG Ratio-0.57
Price/Sales Ratio5.17
Price/Book Ratio15.54
Enterprise/Revenue5.28
Enterprise/EBITDA-18.02

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-0.35
Operating Margin-0.31

Management Effectiveness

Return On Assets-0.28
Return On Equity-1.04

Income Statement

Revenue396.59M
Revenue/Share5.77
Gross Profit338.08M
EBITDA-495.21M
Net Income-528.63M
Diluted EPS-4.45

Balance Sheet

Total Cash396.86M
Total Cash/Share3.2
Total Debt470.45M
Total Debt/Equity1.98
Current Ratio4.36
Book Value Per Share1.91

Price History

52-Week Change-56.3
52-Week High71.9
52-Week Low24.34
Moving Average 50 Days31.83
Moving Average 200 Days35.63

Statistics

Average Volume2.77M
Shares Outstanding124.39M
% Held by Institutions94.49

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.01
Last Split FactorN/A
Last Split DateN/A